New Times,
New Thinking.

  1. Spotlight on Policy
  2. Elections
11 May 2010updated 27 Sep 2015 2:19am

How the Miliband brothers question may yet be resolved

Many expect Ed to run against David. Here’s another theory.

By James Macintyre

The progressive alliance is still in the balance.

What is clear, however, is that the Labour Party will have a new leader by the autumn. Mehdi and I are writing a piece about that race in the issue of the magazine that’s out tomorrow.

In the meantime, it is worth floating one theory that has yet to be aired: at present, the talk is of a race between the Miliband brothers, Ed Balls and possibly one or two others, including Jon Cruddas. But it remains possible that Ed Miliband, whom I first tipped in this magazine in late 2008, will not want to run against his elder brother.

In which case, the already strong hand of the clear favourite, David Miliband, will be strengthened further as Ed Miliband, having gathered support, eventually “does a Gordon” and sacrifices himself to back David.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Ed Miliband is perhaps the most talented rising star of all in Labour. The two brothers together would be a lethal dream ticket. But perhaps this is too clever by half.

Special offer: get 12 issues of the New Statesman for just £5.99 plus a free copy of “Liberty in the Age of Terror” by A C Grayling.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines